Spero Therapeutics Inc. (SPRO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.97
0.02 (2.21%)
At close: Jan 14, 2025, 3:59 PM
0.99
2.55%
After-hours Jan 14, 2025, 06:25 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | 96.73M | 48.58M | 18.26M | 9.33M | 4.74M | 3.97M | 1.98M | 335.00K | n/a |
Cost of Revenue | 367.00K | 1.55M | 1.12M | 67.00M | 65.78M | 33.88M | 32.87M | 26.33M | 11.00K |
Gross Profit | 96.37M | 47.03M | 17.14M | -57.67M | -61.03M | -29.92M | -30.89M | -26.00M | -11.00K |
Operating Income | 21.48M | -42.20M | -87.97M | -79.11M | -63.22M | -42.81M | -41.73M | -33.22M | -13.33M |
Interest Income | 3.94M | 1.11M | 346.00K | 401.00K | 1.33M | 1.14M | 303.00K | n/a | n/a |
Pretax Income | 25.40M | -46.41M | -89.76M | -78.28M | -60.92M | -41.66M | -46.10M | -32.64M | -13.15M |
Net Income | 22.81M | -48.03M | -91.30M | -77.52M | -60.17M | -41.66M | -46.10M | -25.49M | -10.15M |
Selling & General & Admin | 25.55M | 36.48M | 41.70M | 21.44M | 15.59M | 12.89M | 10.84M | 7.22M | 2.20M |
Research & Development | 51.44M | 47.59M | 64.53M | 67.00M | 65.78M | 33.88M | 32.87M | 26.33M | 11.13M |
Other Expenses | -1.74M | -4.93M | -395.00K | 833.00K | -13.40M | 1.14M | -4.37M | n/a | 174.00K |
Operating Expenses | 75.25M | 79.15M | 106.23M | 88.44M | 67.96M | 42.81M | 41.73M | 33.56M | 13.33M |
Interest Expense | n/a | 2.60M | 1.94M | n/a | n/a | 303.00K | 303.00K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 75.25M | 79.15M | 106.23M | 88.44M | 67.96M | 42.81M | 41.73M | 33.56M | 13.33M |
Income Tax | 2.60M | 1.61M | 1.54M | -761.00K | -750.00K | 1.14M | -363.00K | -7.73M | -3.17M |
Shares Outstanding (Basic) | 52.70M | 37.59M | 30.90M | 22.39M | 18.16M | 16.00M | 2.59M | 6.60M | 6.60M |
Shares Outstanding (Diluted) | 52.99M | 37.59M | 30.90M | 22.39M | 18.16M | 16.00M | 2.59M | 6.60M | 6.60M |
EPS (Basic) | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
EPS (Diluted) | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
EBITDA | 25.77M | -42.26M | -87.17M | -76.93M | -62.47M | -42.40M | -41.37M | -32.94M | -13.32M |
Depreciation & Amortization | 367.00K | 1.55M | 1.12M | 1.35M | 1.16M | 409.00K | 363.00K | 279.00K | 11.00K |